BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26540372)

  • 1. Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification.
    Nakamura K; Osada M; Goto A; Iwasa T; Takahashi S; Takizawa N; Akahoshi K; Ochiai T; Nakamura N; Akiho H; Itaba S; Harada N; Iju M; Tanaka M; Kubo H; Somada S; Ihara E; Oda Y; Ito T; Takayanagi R
    Scand J Gastroenterol; 2016; 51(4):448-55. PubMed ID: 26540372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution.
    Sung HY; Kim SW; Kang WK; Kim SY; Jung CK; Cho YK; Park JM; Lee IS; Choi MG; Chung IS
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):978-83. PubMed ID: 22647741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.
    Sekiguchi M; Sekine S; Sakamoto T; Otake Y; Nakajima T; Matsuda T; Taniguchi H; Kushima R; Ohe Y; Saito Y
    J Gastroenterol; 2015 Dec; 50(12):1184-9. PubMed ID: 25936647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.
    Kim J; Kim JH; Lee JY; Chun J; Im JP; Kim JS
    BMC Gastroenterol; 2018 Jun; 18(1):77. PubMed ID: 29866049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.
    Moon CM; Huh KC; Jung SA; Park DI; Kim WH; Jung HM; Koh SJ; Kim JO; Jung Y; Kim KO; Kim JW; Yang DH; Shin JE; Shin SJ; Kim ES; Joo YE
    Am J Gastroenterol; 2016 Sep; 111(9):1276-85. PubMed ID: 27377520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
    Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
    Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of Patients with Small Rectal Neuroendocrine Tumors Treated Using Endoscopic Submucosal Resection with a Ligation Device.
    Takita M; Sakai E; Nakao T; Kimoto Y; Ishii R; Konishi T; Ueno S; Kanda K; Negishi R; Muramoto T; Hashimoto H; Morikawa T; Matsuhashi N; Ohata K
    Digestion; 2019; 99(1):72-78. PubMed ID: 30554202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
    Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
    World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors.
    Cha JH; Jung DH; Kim JH; Youn YH; Park H; Park JJ; Um YJ; Park SJ; Cheon JH; Kim TI; Kim WH; Lee HJ
    Sci Rep; 2019 Mar; 9(1):4911. PubMed ID: 30894571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
    J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic submucosal dissection for treatment of rectal carcinoid tumors.
    Park HW; Byeon JS; Park YS; Yang DH; Yoon SM; Kim KJ; Ye BD; Myung SJ; Yang SK; Kim JH
    Gastrointest Endosc; 2010 Jul; 72(1):143-9. PubMed ID: 20381798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of rectal neuroendocrine tumors ≤ 10 mm following endoscopic resection.
    Kim GU; Kim KJ; Hong SM; Yu ES; Yang DH; Jung KW; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
    Endoscopy; 2013 Dec; 45(12):1018-23. PubMed ID: 24288222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic mucosal resection with suction vs. endoscopic submucosal dissection for small rectal neuroendocrine tumors: a meta-analysis.
    Pan J; Zhang X; Shi Y; Pei Q
    Scand J Gastroenterol; 2018 Sep; 53(9):1139-1145. PubMed ID: 30193543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outcomes of modified endoscopic mucosal resection and endoscopic submucosal dissection for the treatment of rectal neuroendocrine tumors and the value of endoscopic morphology classification in endoscopic resection.
    Wang XY; Chai NL; Linghu EQ; Qiu ST; Li LS; Zou JL; Xiang JY; Li XX
    BMC Gastroenterol; 2020 Jun; 20(1):200. PubMed ID: 32586282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors.
    Park SB; Kim HW; Kang DH; Choi CW; Kim SJ; Nam HS
    World J Gastroenterol; 2015 Aug; 21(31):9387-93. PubMed ID: 26309365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic treatments for rectal neuroendocrine tumors smaller than 16 mm: a meta-analysis.
    Zhang HP; Wu W; Yang S; Lin J
    Scand J Gastroenterol; 2016 Nov; 51(11):1345-53. PubMed ID: 27367942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic submucosal dissection or conventional endoscopic mucosal resection is an effective and safe treatment for rectal carcinoid tumors: a retrospective study.
    Baek IH
    J Laparoendosc Adv Surg Tech A; 2010 May; 20(4):329-31. PubMed ID: 20438309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
    Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
    Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: the investigation and management of rectal neuroendocrine tumours.
    Basuroy R; Haji A; Ramage JK; Quaglia A; Srirajaskanthan R
    Aliment Pharmacol Ther; 2016 Aug; 44(4):332-45. PubMed ID: 27302838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.
    Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L
    Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.